Literature DB >> 8113885

Semiquantitative skull planar and SPECT bone scintigraphy in diabetic patients: differentiation of necrotizing (malignant) external otitis from severe external otitis.

R Hardoff1, S Gips, N Uri, A Front, A Tamir.   

Abstract

UNLABELLED: Early diagnosis of necrotizing external otitis (NEO) includes the use of bone scintigraphy since clinical assessment alone cannot differentiate the necrotizing type of otitis from the severe type of external otitis in which there is no extension to the adjacent bone. Four-hour planar bone scintigraphy may reflect soft-tissue infection, and therefore may not be useful in distinguishing NEO from severe external otitis (SEO). Twenty-four-hour bone scintigraphy using planar or SPECT imaging may better reflect bone uptake and increase the accuracy of the test.
METHODS: Twenty-six diabetic patients (12 diagnosed NEO; 14 SEO) and 10 nondiabetic (ND) patients were studied. Lesion-to-nonlesion (L/N) count ratios obtained from planar and SPECT imaging at 4 hr, 24 hr and 24 hr/4 hr (24/4) were assessed.
RESULTS: Count ratios obtained from the 4- and 24-hr planar and SPECT images were significantly higher in the NEO patients compared to SEO patients for both planar and SPECT studies (p < 0.001, 0.005). The 24/4 count ratio was also significantly higher in the NEO patients on the planar (p < 0.01) and the SPECT studies (p < 0.001). The ND patients were not different from SEO patients on 4-hr planar, 4- and 24-hr SPECT as well as 24/4-hr planar and SPECT studies. The L/N count ratio threshold yielding the best sensitivity for detecting NEO was 1.05 for the 24/4 SPECT study.
CONCLUSION: In diabetic patients, an early distinction between NEO and SEO patients can be reliably made by using L/N count ratios on 24/4 or 24-hr SPECT bone scintigraphy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8113885

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  5 in total

1.  Utility of (99m)Tc-MDP hybrid SPECT-CT for diagnosis of skull base osteomyelitis: comparison with planar bone scintigraphy, SPECT, and CT.

Authors:  Punit Sharma; Krishan Kant Agarwal; Sourav Kumar; Harmandeep Singh; Chandrasekhar Bal; Arun Malhotra; Rakesh Kumar
Journal:  Jpn J Radiol       Date:  2012-10-12       Impact factor: 2.374

2.  Technetium-99m (⁹⁹mTc)-labelled sulesomab in the management of malignant external otitis: is there any role?

Authors:  Francesco Galletti; Giovanni Cammaroto; Bruno Galletti; Natale Quartuccio; Francesca Di Mauro; Sergio Baldari
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-02-18       Impact factor: 2.503

3.  99mTc-HMPAO-leukocyte scintigraphy for diagnosis and therapy monitoring of skull base osteomyelitis.

Authors:  Laura Rozenblum-Beddok; Benjamin Verillaud; Frédéric Paycha; Pierre Vironneau; Mukedaisi Abulizi; Abdel Benada; Tumatarii Cross; Ghada El-Deeb; Nicolas Vodovar; Ilana Peretti; Philippe Herman; Laure Sarda-Mantel
Journal:  Laryngoscope Investig Otolaryngol       Date:  2018-05-14

4.  Additive value of 99mTechnetium methylene diphosphonate hybrid single-photon emission computed tomography/computed tomography in the diagnosis of skull base osteomyelitis in otitis externa patients compared to planar bone scintigraphy.

Authors:  Jehan Ahmed Younis
Journal:  World J Nucl Med       Date:  2018 Oct-Dec

5.  Skull base osteomyelitis in otitis externa: The utility of triphasic and single photon emission computed tomography/computed tomography bone scintigraphy.

Authors:  Dhritiman Chakraborty; Anish Bhattacharya; Ashok Kumar Gupta; Naresh Kumar Panda; Ashim Das; Bhagwant Rai Mittal
Journal:  Indian J Nucl Med       Date:  2013-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.